apollo
logo
0
  1. Home
  2. Medicine
  3. Glycomet 1 GM Tablet 15's
  4. Health Queries for Glycomet 1 GM Tablet 15's
  5. In a 70-year-old male with a 15-year history of Type 2 diabetes, what are the clinical implications of his fasting blood glucose rising from 100 mg/dL to 150 mg/dL and his postprandial blood glucose remaining elevated at 250 mg/dL after switching from a combination of Glimepiride/Metformin and Tenegliptin/Metformin to Voglibose 0.2 mg + Metformin 500 mg twice daily? Furthermore, how should his anti-diabetic regimen be optimized to address this suboptimal glycemic control, and what is the clinical significance of trace yeast cells detected in his recent urinalysis?

health query

Have a query?

In a 70-year-old male with a 15-year history of Type 2 diabetes, what are the clinical implications of his fasting blood glucose rising from 100 mg/dL to 150 mg/dL and his postprandial blood glucose remaining elevated at 250 mg/dL after switching from a combination of Glimepiride/Metformin and Tenegliptin/Metformin to Voglibose 0.2 mg + Metformin 500 mg twice daily? Furthermore, how should his anti-diabetic regimen be optimized to address this suboptimal glycemic control, and what is the clinical significance of trace yeast cells detected in his recent urinalysis?

Asked by Male, 71 · 12 days ago

Switching to your current regimen of voglibose and metformin likely reduced the overall strength of your treatment compared to your previous combination, leading to these higher blood sugar readings. To optimize your control, your doctor may need to adjust your dosages or reinstate helper medications like a DPP-4 inhibitor or sulfonylurea. Regarding the trace yeast in your urine, this is very common when blood sugars are elevated, as excess sugar in the urine encourages mild yeast growth. It is usually harmless but highlights the need to gently bring your glucose levels back into balance. Please consult your doctor soon to safely adjust your plan.
user icon

Ask Apollo

AI powered Health Chatbot

In a 70-year-old male with a 15-year history of Type 2 diabetes, what are the clinical implications of his fasting blood glucose rising from 100 mg/dL to 150 mg/dL and his postprandial blood glucose remaining elevated at 250 mg/dL after switching from a combination of Glimepiride/Metformin and Tenegliptin/Metformin to Voglibose 0.2 mg + Metformin 500 mg twice daily? Furthermore, how should his anti-diabetic regimen be optimized to address this suboptimal glycemic control, and what is the clinical significance of trace yeast cells detected in his recent urinalysis?

Answered 12 days ago

Related Questions